237 related articles for article (PubMed ID: 3181485)
21. Histological and clinical features of menstruation induced by the antiprogestin mifepristone (RU486) compared to menstruation occurring spontaneously.
Li TC; Dockery P; Rogers AW; Cooke ID
J Obstet Gynaecol (Lahore); 1990; 10(5):411-4. PubMed ID: 12283861
[TBL] [Abstract][Full Text] [Related]
22. Response to intermittent RU486 in women.
Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[TBL] [Abstract][Full Text] [Related]
23. Effect of tamoxifen alone and in combination with RU 486 on the endometrium in the mid-luteal phase.
Swahn ML; Bygdeman M; Seppälä M; Johannisson E; Cekan S
Hum Reprod; 1993 Feb; 8(2):193-200. PubMed ID: 8473418
[TBL] [Abstract][Full Text] [Related]
24. Effect of the antiprogestin RU486 on progesterone production by cultured human granulosa cells: inhibition of the ovarian 3B-hydroxysteroid dehydrogenase.
Dimattina M; Albertson B; Seyler DE; Loriaux DL; Falk RJ
Contraception; 1986 Aug; 34(2):199-206. PubMed ID: 2946554
[TBL] [Abstract][Full Text] [Related]
25. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
[TBL] [Abstract][Full Text] [Related]
26. Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation.
Kekkonen R; Croxatto HB; Lähteenmäki P; Salvatierra AM; Tuominen J
Hum Reprod; 1995 Feb; 10(2):287-92. PubMed ID: 7769050
[TBL] [Abstract][Full Text] [Related]
27. The role of pre-ovulatory progesterone in the midcycle gonadotrophin surge, ovulation and subsequent luteal phase: studies with RU486 in rhesus monkeys.
Remohi J; Balmaceda JP; Rojas FJ; Asch RH
Hum Reprod; 1988 May; 3(4):431-5. PubMed ID: 3134390
[TBL] [Abstract][Full Text] [Related]
28. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
29. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
[TBL] [Abstract][Full Text] [Related]
30. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
31. Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase.
Shumin X; Johannisson E; Landgren BM; Diczfalusy E
Contraception; 1983 Feb; 27(2):177-93. PubMed ID: 6851555
[TBL] [Abstract][Full Text] [Related]
32. Endometrial effects of long-term low-dose administration of RU486.
Murphy AA; Kettel LM; Morales AJ; Roberts V; Parmley T; Yen SS
Fertil Steril; 1995 Apr; 63(4):761-6. PubMed ID: 7890059
[TBL] [Abstract][Full Text] [Related]
33. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
Bergquist C; Nillius SJ; Wide L
Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
[TBL] [Abstract][Full Text] [Related]
34. Progesterone receptor antagonists and prostaglandins in human fertility regulation: a clinical review.
Healy DL
Reprod Fertil Dev; 1990; 2(5):477-90. PubMed ID: 1963697
[TBL] [Abstract][Full Text] [Related]
35. Effects of long-term low-dose mifepristone on reproductive function in women.
Croxatto HB; Kovács L; Massai R; Resch BA; Fuentealba B; Salvatierra AM; Croxatto HD; Zalányi S; Viski S; Krenács L
Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
[TBL] [Abstract][Full Text] [Related]
36. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
Gaillard RC; Herrmann W
Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522
[TBL] [Abstract][Full Text] [Related]
37. Luteolysis in humans and subhuman primates.
Henzl MR
Res Prostaglandins; 1972 May; 1(5):1-3. PubMed ID: 12337004
[TBL] [Abstract][Full Text] [Related]
38. Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility.
Sheehan KL; Casper RF; Yen SS
Fertil Steril; 1982 Feb; 37(2):209-12. PubMed ID: 7037463
[TBL] [Abstract][Full Text] [Related]
39. Correlation between endometrial biopsy and serum progesterone level in prediction of corpus luteum function.
El-hefnawi N; Abou-gabal A; El-etriby A; Maged M; Wafa G; Ragab I
Popul Sci; 1987; 7():139-51. PubMed ID: 12315537
[TBL] [Abstract][Full Text] [Related]
40. [The effect of RU486 and progesterone on luteal function during pregnancy].
Yamabe S; Katayama K; Mochizuki M
Nihon Naibunpi Gakkai Zasshi; 1989 May; 65(5):497-511. PubMed ID: 2776921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
